Franklin Biotechnology Discv C(acc)USD

Performance History31/08/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv C(acc)USD
Fund101.547.939.8-28.016.5
+/-Cat6.53.9-3.81.0-1.6
+/-Idx-5.63.5-4.4-5.5-0.3
 
Key Stats
NAV
19/09/2017
 USD 39.32
Day Change -0.08%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0260873095
Fund Size (Mil)
31/08/2017
 USD 2724.39
Share Class Size (Mil)
31/08/2017
 USD 19.59
Max Initial Charge -
Ongoing Charge
27/01/2017
  2.41%
Investment Objective: Franklin Biotechnology Discv C(acc)USD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns19/09/2017
YTD18.86
3 Years Annualised11.02
5 Years Annualised28.10
10 Years Annualised20.45
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
01/09/2006
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv C(acc)USD31/07/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.830.0096.83
Bonds0.000.000.00
Cash2.210.002.21
Other0.960.000.96
Top 5 Regions%
United States97.04
Middle East0.92
United Kingdom0.73
Eurozone0.54
Canada0.43
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.71
Alexion Pharmaceuticals IncHealthcareHealthcare8.32
Incyte CorpHealthcareHealthcare5.98
Regeneron Pharmaceuticals IncHealthcareHealthcare5.35
Biogen IncHealthcareHealthcare4.70
Franklin Biotechnology Discv C(acc)USD